<?xml version="1.0" encoding="UTF-8"?>
<ref id="B109-biomedicines-08-00109">
 <label>109.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Drabek</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Okba</surname>
    <given-names>N.M.A.</given-names>
   </name>
   <name>
    <surname>van Haperen</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>van Kupperveld</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Haagmans</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Grosveld</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Bosch</surname>
    <given-names>B.-J.</given-names>
   </name>
  </person-group>
  <article-title>A human monoclonal antibody blocking SARS-CoV infection</article-title>
  <source>bioRxiv</source>
  <year>2020</year>
  <comment>preprint</comment>
  <pub-id pub-id-type="doi">10.1101/2020.03.11.987958</pub-id>
 </element-citation>
</ref>
